Posted on 12/24/19
SNHMC, Elliot Hospital Receive Awards for Organ Donor Efforts
NASHUA, N.H.--(BUSINESS WIRE)--Southern New Hampshire Medical Center was awarded gold level recognition for the first time in the National Hospital Organ Donation Campaign for its efforts . . .
Posted on 12/24/19
Exicure Closes its Offering of Common Stock
CHICAGO, Ill. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today announced the . . .
Posted on 12/23/19
Stoke Therapeutics Added to NASDAQ Biotechnology Index
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq:STOK), a biotechnology company pioneering a new way to treat the underlying cause of severe genetic diseases by precisely upregulating protein . . .
Posted on 12/23/19
How Gilead Sciences Is Helping Fund Bristol-Myers Squibb's Celgene Acquisition
Bristol-Myers Squibb (NYSE:BMY) closed on its acquisition of Celgene in November. The big drugmaker announced plans to buy Celgene earlier this year for $74 billion. That . . .
Posted on 12/23/19
Stealth BioTherapeutics Provides Update on Phase 3 Trial of Elamipretide in Primary Mitochondrial Myopathy
Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced top-line . . .
Posted on 12/19/19
Exicure Prices $27.5M Public Offering of Common Stock
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, today announced the pricing . . .
Posted on 12/19/19
FORMA Therapeutics Announces Closing of $100 Million Series D Financing
FORMA Therapeutics, Inc., a clinical stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the closing of $100 million Series D financing.
Posted on 12/19/19
Rheos Medicines Announces Worldwide Collaboration with Roche
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Rheos Medicines (Rheos), a biopharmaceutical company harnessing insights in immunometabolism to create a new class of therapeutics for patients with severe autoimmune disorders, inflammatory . . .
Posted on 12/19/19
Dicerna Announces Closing of Worldwide Collaboration and Licensing Agreement With Roche
LEXINGTON, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced the successful closing of the research collaboration . . .
Posted on 12/19/19
Cara Therapeutics: Recent Stock Price Plunge Was A Bit Exaggerated
SummaryThe company reported positive Phase II clinical results of oral KORSUVA showing a strong efficacy and safety profile compared to placebo.Management stated that the response rate . . .
Posted on 12/19/19
Voluntis Announces New Pharma Collaboration in Oncology
CAMBRIDGE, Mass. & PARIS--(BUSINESS WIRE)--Voluntis (Paris:VTX) (Euronext Paris, Ticker: VTX - ISIN: FR0004183960), a leader in digital therapeutics, announced today a collaboration with Novartis to evaluate . . .
Posted on 12/19/19
Exicure Proposes Public Offering of Common Stock
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, announced today that it . . .
Posted on 12/18/19
New York Life to Acquire Cigna’s Group Life and Disability Insurance Business
NEW YORK & BLOOMFIELD, Conn.--(BUSINESS WIRE)--New York Life, America’s largest mutual life insurer, and Cigna, a leading global health service company, announced today that they have . . .
Posted on 12/18/19
Sarepta Therapeutics: FDA Approval Reinstalls Confidence In The Pipeline
SummarySarepta Therapeutics publicized its accelerated FDA approval for its DMD drug Vyondys 53. The SRPT has spiked up over 30%, but it is still worth a . . .
Posted on 12/17/19
LogicBio Therapeutics Extends Sponsored Research Agreement with Oregon Health & Science University
CAMBRIDGE, Mass., Dec. 17, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases in . . .
Posted on 12/17/19
TMRW Life Sciences Raises $25 Million In Series B Funding Led By 5AM Ventures
TMRW Life Sciences, creator of ivfOS, an integrated platform for automated, software-guided embryology and cryo-management, announced today it has closed $25 million in Series B
Posted on 12/17/19
Cerevance Enters Research Collaboration with Takeda
BOSTON & CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--Cerevance, a clinical stage biopharmaceutical company advancing new medicines for brain diseases, has formed a multi-year research alliance with Takeda Pharmaceutical . . .
Posted on 12/17/19
Triplet Therapeutics Launches with $59M In Financing
Triplet Therapeutics, Inc., a biotechnology company harnessing human genetics to develop treatments for repeat expansion disorders at their source
Posted on 12/17/19
Cerence Announces Fourth Quarter and Fiscal Year 2019 Results
BURLINGTON, Mass., Dec. 17, 2019 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today reported its fourth quarter and fiscal year . . .
Posted on 12/17/19
bluebird bio's Advancement With Zynteglo Gene Therapy Is Properly Set Up For Commercial Success
Summarybluebird bio announced a positive, long-term follow-up of 5 years for beta-thalassemia patients who have been transfusion-free for an extended period of time.The rolling BLA submission . . .
Posted on 12/17/19
Bristol-Myers Placed A Big Bet On Celgene’s Pipeline. Will It Pay Off For Investors?
On Nov. 20, Bristol-Myers Squibb (NYSE:BMY) announced the completion of its $74 billion acquisition of Celgene (NASDAQ:CELG). Bristol-Myers' strategy centers on merging an innovative, agile biotechnology . . .
Posted on 12/16/19
Platelet BioGenesis Receives $2.3M Award from the Medical Technology Enterprise Consortium
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Platelet BioGenesis, Inc. (PBG), the leader in stem cell-derived, on-demand human platelets (PLTs+™) and genetically engineered platelet-based therapeutics, announced today it received an award . . .
Posted on 12/16/19
Charles River Laboratories To Acquire HemaCare
Charles River Laboratories International, Inc. (NYSE: CRL) and HemaCare Corporation (OTCMKTS: HEMA) announced today a definitive agreement
Posted on 12/16/19
Is Biogen Too Cheap to Ignore?
Biogen's (NASDAQ:BIIB) run on the stock market this year has been a roller-coaster ride, to say the least. In March, the company's shares fell off a . . .
Posted on 12/16/19
A Warren Buffett Investment That You Don’t Want To Own
Normally, it isn't wise to go up against Berkshire Hathaway, but that is exactly what Jim Chanos is doing with his position in DaVita (NYSE:DVA). In . . .

